CRISPR activation of DLX5 drives neural progenitors to the GnRH cell fate
Journal of Molecular Endocrinology · 01.07.2026 · 77 (1)
DOI: 10.1530/jme-26-0040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Molecular Endocrinology, online erschienen am 14.07.2026. Verfasst von Shrinidhi Madhusudan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki , Helsinki, Finland. Hauptthemen laut MEDLINE: Gonadotropin-Releasing Hormone, Homeodomain Proteins, Neural Stem Cells, CRISPR-Cas Systems. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gonadotropin-releasing hormone (GnRH) neurons regulate the hypothalamic–pituitary–gonadal (HPG) axis and are required for puberty onset and reproductive competence. However, the transcriptional regulators governing GnRH neuron specification and migration remain poorly defined. The homeodomain transcription factor DLX5 is expressed in fetal human GnRH neurons, its expression precedes that of GNRH1 in human pluripotent stem cell (hPSC)-derived GnRH neurons, and in mice, it serves as a guidance cue for GnRH neuron migration. We hypothesized that DLX5 may act as an upstream regulator of human GnRH neuron fate specification and migratory capacity. Using CRISPR activation, we upregulated DLX5 during FGF8b-directed differentiation of hPSCs to GnRH neurons via dual SMAD inhibition and Notch inhibition, as previously described. DLX5 activation increased neural progenitor motility (P < 0.001), upregulated FGF8 (P < 0.05), and induced GABAergic markers, including GAD1 and GAD2. Notably, DLX5 activation induced GNRH1 in the absence of exogenous FGF8b (P < 0.05), suggesting that in GnRH neurons, DLX5 regulates FGF8. When combined with exogenous FGF8b, DLX5 activation produced distinct neuronal patterning accompanied by upregulation of extracellular matrix genes, such as SPARC, which has been implicated in neurite outgrowth. Collectively, these data indicate that activation of DLX5 promotes GnRH neurogenesis from hPSCs, by driving GABAergic fate, inducing FGF8, and remodeling the extracellular matrix.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stem Cells and Metabolism Research Program (STEMM), Research Programs Unit, Faculty of Medicine, University of Helsinki , Helsinki, Finland.
- Medicum, Faculty of Medicine, University of Helsinki , Helsinki, Finland.
- Estonian Genome Center, Institute of Genomics, University of Tartu , Tartu, Estonia.
- Turku Bioscience Centre, University of Turku and Åbo Akademi University , Turku, Finland.
- Department of Biochemistry and Developmental Biology, Faculty of Medicine, University of Helsinki , Helsinki, Finland.
- Pediatric Research Center, Helsinki University Hospital, New Children's Hospital , Helsinki, Finland.
ORCID-Profile: Shrinidhi Madhusudan
Zitieren
APA
Madhusudan, S., Eskici, N., Gomez-Sanchez, C., Pulli, K., Vaaralahti, K., Yellapragada, V., Conway, J. R. W., Wang, Y., & Raivio, T. (2026). CRISPR activation of DLX5 drives neural progenitors to the GnRH cell fate. Journal of Molecular Endocrinology, 77(1). https://doi.org/10.1530/jme-26-0040
Vancouver
Madhusudan S, Eskici N, Gomez-Sanchez C, Pulli K, Vaaralahti K, Yellapragada V, et al. CRISPR activation of DLX5 drives neural progenitors to the GnRH cell fate. Journal of Molecular Endocrinology. 2026;77(1). doi:10.1530/jme-26-0040
BibTeX
@article{Madhusudan2026,
author = {Madhusudan, Shrinidhi and Eskici, Nazli and Gomez-Sanchez, Celia and Pulli, Kristiina and Vaaralahti, Kirsi and Yellapragada, Venkatram and Conway, James R W and Wang, Yafei and Raivio, Taneli},
title = {CRISPR activation of DLX5 drives neural progenitors to the GnRH cell fate},
journal = {Journal of Molecular Endocrinology},
year = {2026},
volume = {77},
number = {1},
doi = {10.1530/jme-26-0040}
}
EUVIMED